allows these assays to be carried out at a large scale. In vitro cellular infection assays can 37 function as a preliminary screening tool, for vaccine development or antimicrobial screening, 38 and also to extend findings derived from experimental animal trials. Currently using culture, 39 it takes up to four months to get quantifiable results regarding MAP viability after an in vitro 40 infection assay, however with the quantitative PCR and liquid culture method developed, 41 reliable results can be obtained at two weeks. This method will be important in vaccine and
INTRODUCTION

46
Determining the number of live and dead bacteria in a sample is a key requirement of 47 most in vitro cellular infection/phagocytosis assays. Quantification of live and dead bacteria 48 is generally done by assessing growth in culture (1). However, for fastidious slow growing 49 bacteria, such as Mycobacterium avium subspecies paratuberculosis (MAP), it can take 50 months to obtain culture results (2-4). This becomes a significant obstacle for in vitro cellular 51 infection assays, which precludes their use in large studies.
52
In vitro cellular infection assays could be a rapid and cost effective alternative to 53 animal trials for assessing MAP interactions with host immune cells. Through examination of 54 interaction outcomes, these assays can provide information relevant to assessment of vaccine 55 efficacy (5-7), pathogenesis (8), and antimicrobial activity (9). However, if in vitro infection 56 assays are to be used as rapid screening tools it is essential that they function in a high 57 throughput capacity for large studies, and that the time taken to obtain results does not 58 become rate limiting. 59 Culture is the gold standard method for confirming the presence of viable bacteria in a 60 sample. Liquid culture is recommended for primary isolation of MAP, because it is more 61 sensitive than culture on solid medium (1). The presence of MAP in liquid culture can be 62 confirmed rapidly by polymerase chain reaction (PCR) (10). The amount of MAP in a sample 63 can be determined by quantitative-PCR (qPCR) however it does not discriminate between 64 DNA from live and dead bacteria, making it unable to determine the viability of bacteria 5 required, particularly the suggested amount of dye, the cell concentration and the staining 94 protocol which all can vary depending on the readout method. irreversibly alters the DNA structure and strongly interferes with qPCR detection (12, 22) . 100 However, differentiation of the amount of DNA from treated and untreated MAP samples has 101 proven to be difficult (23, 24) . Differentiation of these samples may be enhanced by 102 optimisation of incubation time and dye concentration and make this assay suitable for 103 detection of MAP in an in vitro cellular infection assay. 104 The aim of this study was to develop an assay to quantify the number of viable MAP 105 in a sample with sufficient sensitivity at low cell concentrations, to enable application to an in 106 vitro cellular infection model. The initial objective was to screen three different non-culture 107 dependent viability assays, followed by evaluation of a qPCR-coupled rapid culture protocol.
108
The expected criteria for assessment included accurate live/dead discrimination, assay 109 sensitivity and ability for MAP viability to be rapidly quantified. showed a detectable reduction of the dye (FIG 1 D) . .933) and no significant interaction of the two (F(6,12) = 0.23, p = .960) (FIG 3) .
110
MATERIALS AND METHODS
357
Interestingly, the same amount of DNA recovered from samples that were treated with PMA 358 and exposed to light as was recovered from their untreated and unexposed counterparts.
359
MAP culture and IS900 quantitative PCR method for the detection of viable MAP. 
